+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-Animal Alternatives Testing Global Market Report 2024

  • PDF Icon

    Report

  • 250 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5939773
The non-animal alternatives testing market size has grown rapidly in recent years. It will grow from $2.08 billion in 2023 to $2.33 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The expansion observed in the historical period can be credited to robust economic growth in emerging markets, elevated expenses associated with animal studies, a growing embrace of in-vitro and in-silico technologies in fundamental research, heightened investments, increased research grants dedicated to developing alternative technologies, and a rising societal consciousness opposing animal cruelty.

The non-animal alternatives testing market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The anticipated growth in the forecast period can be ascribed to government initiatives supporting non-animal alternative testing, an increase in research and development activities, and ethical reservations regarding animal experiments, all contributing to market expansion. Key trends expected in this period involve an emphasis on advancing organs-on-chips (OOC) technology, the utilization of in silico trials, the development of advanced 3D bio-printed organs and tissues, the incorporation of model organisms, strategic collaborations and partnerships, and a surge in initiatives and grants aimed at promoting animal-free testing.

The growth of the non-animal testing market is propelled by support from both government and non-governmental organizations. Government entities enforce regulations, enact laws, and allocate funds to endorse non-animal testing methods, including tests on human volunteers and advanced computer-modeling techniques. People for the Ethical Treatment of Animals (PETA) India, for example, demonstrated its commitment to advancing animal-free methods for toxicology testing by announcing a grant of 7 lakh rupees in 2022. Similar initiatives promoting non-animal testing procedures are also undertaken by countries such as Denmark, Brazil, Germany, Switzerland, Australia, China, and Korea. The consistent support from governmental and non-governmental sources plays a pivotal role in driving the growth of the non-animal testing market.

The anticipated expansion of the non-animal alternative testing market is expected to be driven by rising healthcare expenditure in the future. Healthcare expenditure, which encompasses spending on healthcare costs, reflects the total financial investment in healthcare-related goods and services within a specific healthcare system or economy. This expenditure is instrumental in fostering the development and accessibility of non-animal alternative testing activities. As an example, data from November 2022, as reported by the Canadian Institute for Health Information, indicates a rise in healthcare expenditure to 0.8%, amounting to $331 billion in 2022 compared to 7.6% in 2021. Consequently, the upward trajectory in healthcare expenditure is contributing to the growth of the non-animal alternative testing market.

Leading companies in the non-animal alternative testing sector are engaging in collaborations to advance alternatives to animal testing and gain a competitive advantage in the market. These collaborations serve to expedite the adoption of animal-free safety science. For example, in February 2023, Unilever, a UK-based healthcare product manufacturer, partnered with a global coalition of cosmetics manufacturers, suppliers, industry associations, and animal protection organizations. The objective of this collaboration is to promote innovation in animal-free cosmetics, personal care products, and ingredients. The partnership involves funding and scientific evaluation of new safety assessment approaches, aiming to instill confidence in animal-free safety science.

Major companies in non-animal alternative testing are also spearheading the development of innovative products such as Digital Animal Replacement Technology (DART). This technology provides a humane and accurate substitute for animal testing by utilizing ethically sourced human stem cells, a digital workstation, and artificial intelligence to predict drug safety based on stem cell-drug interactions. For instance, in June 2023, Quantifi, a US-based software company, introduced Digital Animal Replacement Technology (DART). This technology not only facilitates early-stage decision-making, cost reduction, and improved time-to-market but also offers advantages such as accelerated testing, customization based on genetic profiles, and relevance to human physiology.


Major companies operating in the non-animal alternatives testing market report are Evotec SE (Cyprotex), Bio-Rad Laboratories, Inc., BioIVT, Emulate, Inc., MatTek Corporation, SGS SA, Gentronix Limited, Promega Corporation, InSphero, VITROCELL Systems GmbH, Abbott India Limited, Becton Dickinson Private Limited, Biocartis Group NV, Bio-Techne India Private Limited, Danaher, Cleaver Scientific, China Tissue Engineering Co., Ltd. (J-TEC), Reprocell, Inc., Organ Technologies Co. Ltd., Mimetas, JRF Global, PharmaCo-Cell Company Ltd., Vessel Inc., Modulus Discovery, Sanofi, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Qiagen N.V, bioMérieux SA, QuantuMDx, Interlabservis, Roche Diagnostics, GeneMe, TestLine Clinical Diagnostics s.r.o, Thermo Fisher Scientific, PerkinElmer, GE Healthcare, Waters Corporation, Agilent Technologies, Bruker Corporation, Oxford Nanopore Technologies, 10x Genomics, Organovo Holdings, EMD Millipore, Cyprotex, RegeneMed Inc., HμREL Corporation, Nortis, In Silico Biosciences Inc., IOMICS Corporation, Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Inc., Cyagen Biosciences, Crown Biosciences, Harbour BioMed, Genewiz, Pacific Biosciences, Group 42 (G42) Healthcare, I-ONE, Wadi Jeddah Co, Philips, King Abdullah International Medical Research Center, Parexel, Soins Global, Pfizer South Africa, Dischem Pharmacy, Cipla Medpro South Africa Limited, Novartis South Africa, Synexa Life Sciences, IQVIA, Oceanic S. A, Hean.

North America was the largest region in the non-animal alternatives testing in 2023. Western Europe was the second-largest region in the non-animal alternatives testing market report. The regions covered in the non-animal alternatives testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-animal alternatives testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain. The non-animal alternatives testing market consists of revenue earned by that perform organs-on-chips (OOCs) technology, and 3D bio-printing of tissues among others. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The primary techniques in non-animal alternative testing include cellular assay, biochemical assay, in silico modeling, and ex-vivo methods. A biochemical assay is an analytical process conducted in vitro to detect, quantify, or explore the binding or activity of biological molecules such as enzymes. Various technologies play a crucial role in these methods, including cell culture technology, high-throughput technology, molecular imaging, omics technology, and others. Industries such as pharmaceuticals, cosmetics, household products, diagnostics, chemicals, and food utilize these technologies as alternatives to animal testing.

The non-animal alternatives testing market research report is one of a series of new reports that provides non-animal alternatives testing market statistics, including non-animal alternatives testing industry global market size, regional shares, competitors with a non-animal alternatives testing market share, detailed non-animal alternatives testing market segments, market trends and opportunities, and any further data you may need to thrive in the non-animal alternatives testing industry. This non-animal alternatives testing market research report provides a comprehensive view of everything you require, including an in-depth analysis of the industry's current and future scenario.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Non-Animal Alternatives Testing Market Characteristics3. Non-Animal Alternatives Testing Market Trends and Strategies
4. Non-Animal Alternatives Testing Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Non-Animal Alternatives Testing Market Size and Growth
5.1. Global Non-Animal Alternatives Testing Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Non-Animal Alternatives Testing Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Non-Animal Alternatives Testing Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Non-Animal Alternatives Testing Market Segmentation
6.1. Global Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • Omics Technology
  • Other Technologies
6.2. Global Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cellular Assay
  • Biochemical Assay
  • in Silico
  • Ex-vivo
6.3. Global Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Diagnostics
  • Chemicals Industry
  • Food Industry
7. Non-Animal Alternatives Testing Market Regional and Country Analysis
7.1. Global Non-Animal Alternatives Testing Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Non-Animal Alternatives Testing Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Non-Animal Alternatives Testing Market
8.1. Asia-Pacific Non-Animal Alternatives Testing Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Non-Animal Alternatives Testing Market
9.1. China Non-Animal Alternatives Testing Market Overview
9.2. China Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Non-Animal Alternatives Testing Market
10.1. India Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Non-Animal Alternatives Testing Market
11.1. Japan Non-Animal Alternatives Testing Market Overview
11.2. Japan Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Non-Animal Alternatives Testing Market
12.1. Australia Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Non-Animal Alternatives Testing Market
13.1. Indonesia Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Non-Animal Alternatives Testing Market
14.1. South Korea Non-Animal Alternatives Testing Market Overview
14.2. South Korea Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Non-Animal Alternatives Testing Market
15.1. Western Europe Non-Animal Alternatives Testing Market Overview
15.2. Western Europe Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Non-Animal Alternatives Testing Market
16.1. UK Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Non-Animal Alternatives Testing Market
17.1. Germany Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Non-Animal Alternatives Testing Market
18.1. France Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Non-Animal Alternatives Testing Market
19.1. Italy Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Non-Animal Alternatives Testing Market
20.1. Spain Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Non-Animal Alternatives Testing Market
21.1. Eastern Europe Non-Animal Alternatives Testing Market Overview
21.2. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Non-Animal Alternatives Testing Market
22.1. Russia Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Non-Animal Alternatives Testing Market
23.1. North America Non-Animal Alternatives Testing Market Overview
23.2. North America Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Non-Animal Alternatives Testing Market
24.1. USA Non-Animal Alternatives Testing Market Overview
24.2. USA Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Non-Animal Alternatives Testing Market
25.1. Canada Non-Animal Alternatives Testing Market Overview
25.2. Canada Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Non-Animal Alternatives Testing Market
26.1. South America Non-Animal Alternatives Testing Market Overview
26.2. South America Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Non-Animal Alternatives Testing Market
27.1. Brazil Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Non-Animal Alternatives Testing Market
28.1. Middle East Non-Animal Alternatives Testing Market Overview
28.2. Middle East Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Non-Animal Alternatives Testing Market
29.1. Africa Non-Animal Alternatives Testing Market Overview
29.2. Africa Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Non-Animal Alternatives Testing Market Competitive Landscape and Company Profiles
30.1. Non-Animal Alternatives Testing Market Competitive Landscape
30.2. Non-Animal Alternatives Testing Market Company Profiles
30.2.1. Evotec SE (Cyprotex)
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Bio-Rad Laboratories, Inc
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. BioIVT
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Emulate, Inc
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. MatTek Corporation
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Non-Animal Alternatives Testing Market Other Major and Innovative Companies
31.1. SGS SA
31.2. Gentronix Limited
31.3. Promega Corporation
31.4. InSphero
31.5. VITROCELL Systems GmbH
31.6. Abbott India Limited
31.7. Becton Dickinson Private Limited
31.8. Biocartis Group NV
31.9. Bio-Techne India Private Limited
31.10. Danaher
31.11. Cleaver Scientific
31.12. China Tissue Engineering Co., Ltd. (J-TEC)
31.13. Reprocell, Inc.
31.14. Organ Technologies Co. Ltd
31.15. Mimetas
32. Global Non-Animal Alternatives Testing Market Competitive Benchmarking33. Global Non-Animal Alternatives Testing Market Competitive Dashboard34. Key Mergers and Acquisitions in the Non-Animal Alternatives Testing Market
35. Non-Animal Alternatives Testing Market Future Outlook and Potential Analysis
35.1 Non-Animal Alternatives Testing Market in 2028 - Countries Offering Most New Opportunities
35.2 Non-Animal Alternatives Testing Market in 2028 - Segments Offering Most New Opportunities
35.3 Non-Animal Alternatives Testing Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Non-Animal Alternatives Testing Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-animal alternatives testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for non-animal alternatives testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology; Other Technologies
2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-Vivo
3) By End-user: Pharmaceutical Industry; Cosmetics and Household Products; Diagnostics; Chemicals Industry; Food and Beverage Industry; Other End-users

Key Companies Mentioned: Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned

  • Evotec SE (Cyprotex)
  • Bio-Rad Laboratories, Inc
  • BioIVT
  • Emulate, Inc
  • MatTek Corporation
  • SGS SA
  • Gentronix Limited
  • Promega Corporation
  • InSphero
  • VITROCELL Systems GmbH
  • Abbott India Limited
  • Becton Dickinson Private Limited
  • Biocartis Group NV
  • Bio-Techne India Private Limited
  • Danaher
  • Cleaver Scientific
  • China Tissue Engineering Co., Ltd. (J-TEC)
  • Reprocell, Inc.
  • Organ Technologies Co. Ltd
  • Mimetas
  • JRF Global
  • PharmaCo-Cell Company Ltd
  • Vessel Inc
  • Modulus Discovery
  • Sanofi
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Qiagen N.V
  • bioMérieux SA
  • QuantuMDx
  • Interlabservis
  • Roche Diagnostics
  • GeneMe
  • TestLine Clinical Diagnostics s.r.o
  • Thermo Fisher Scientific
  • PerkinElmer
  • GE Healthcare
  • Waters Corporation
  • Agilent Technologies
  • Bruker Corporation
  • Oxford Nanopore Technologies
  • 10x Genomics
  • Organovo Holdings
  • EMD Millipore
  • Cyprotex
  • RegeneMed Inc
  • HμREL Corporation
  • Nortis
  • In Silico Biosciences Inc
  • IOMICS Corporation
  • Charles River Laboratories
  • The Jackson Laboratory
  • Envigo
  • Taconic Biosciences, Inc.
  • Cyagen Biosciences
  • Crown Biosciences
  • Harbour BioMed
  • Genewiz
  • Pacific Biosciences
  • Group 42 (G42) Healthcare
  • I-ONE
  • Wadi Jeddah Co
  • Philips
  • King Abdullah International Medical Research Center
  • Parexel
  • Soins Global
  • Pfizer South Africa
  • Dischem Pharmacy
  • Cipla Medpro South Africa Limited
  • Novartis South Africa
  • Synexa Life Sciences
  • IQVIA
  • Oceanic S. A
  • Hean

Methodology

Loading
LOADING...